期刊文献+

从门静脉癌栓建立肝癌细胞株及对其细胞遗传特征的研究 被引量:2

Establishment and Cytogenetic Characterization of A Human Hepatocellular Carcinoma Cell Strain from the Embolus in Portal Vein
下载PDF
导出
摘要 背景和目的:肝细胞癌(hepatocellularcarcinoma,HCC)预后差的原因是术后复发率高和早期通过门静脉转移。本研究建立门静脉癌栓肝癌细胞株,并探讨其分子细胞遗传特征。方法:从HCC患者门脉癌栓中获取肝癌细胞进行细胞培养,对培养成功的细胞(H4M)进行染色体G带染色后分析其核型和对比基因组杂交(comparativegenomichybridization,CGH)结果;用差异PCR检测周期素D1基因。结果:H4M细胞核型为超3倍体,染色体数为71~78,其中有一条标记染色体含有一长的均染区(hsr)。H4M主要的细胞遗传学改变为8p缺失和11q13高拷贝数扩增。周期素D1基因CCND1明显扩增。结论:染色体8p丢失和11q13高拷贝数扩增与H4M细胞的转移特性相关。周期素D1基因CCND1扩增可能是染色体11q13扩增的原因。 Background & Objective: Poor prognosis of hepatocellular carcinoma (HCC) is due to its high recurrent rate after operation and early metastasis through portal vein. This study was designed to establish a metastatic HCC cell line and to investigate its molecular and cytogenetic characterization. Methods: Cell culture was performed using the tissue obtained from a metastatic lesion in portal vein of a patient with HCC. After G banding staining,karyotype, and comparative genomic hybridization (CGH) of the cultured H4M cells were characterized and cyclin D1 gene CCND1 was detected by differential PCR. Results: The karyotype of metastatic HCC cell strain is a hypertriploid (71~78 chromosomes) with a huge marker chromosome containing a long homogeneously staining region (hsr). The main genetic alterations in H4M cells were a high copy number amplification of 11q13 and loss of 8p. Cyclin D1 gene CCND1 was also amplified significantly in the cells. Conclusions: The loss of chromosome 8p and high copy number amplification of 11q13 are associated with the metastatic characterics of H4M cells. The amplification of cyclin D1 gene CCND1 in H4M cells may be the cause of the amplification of chromosome 11q13.
出处 《癌症》 SCIE CAS CSCD 北大核心 2002年第11期1203-1207,共5页 Chinese Journal of Cancer
基金 中国杰出青年科学家基金资助项目(No.39825511)
关键词 门静脉癌栓 肝癌细胞株 细胞遗传特征 研究 Hepatocellular carcinoma Cell strain Karyotype Comparative genomic hybridization Cyclin D1 gene
  • 相关文献

参考文献10

  • 1Okuda K. New trends in hepatocellular carcinoma [J]. Int J Clin Lab Res, 1993, 23(4):173- 178.
  • 2Guan XY, Fang Y, Sham JST, et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization [J]. Gene Chromosome Cancer, 2000, 29(2):110- 116.
  • 3Kyomoto R, Kumazawa H, Toda Y, et al. Cyclin-D1-gene amplification is a more potent prognosis factor than its protein over-expression in human head-and-neck squamous-cell carcinoma [J]. Int J Cancer, 1997, 74(6):576- 581.
  • 4Qin LX, Tang ZY, Sham JST, et al. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma [J]. Cancer Res, 1999, 59(22):5662- 5665.
  • 5Takanishi DM, Jr Kim SY, Kelemen PR, et al. Chromosome 8 losses in colorectal carcinoma: Localization and correlation with invasive disease [J]. Mol Diagn, 1997, 2(1):3- 10.
  • 6Bissig H, Richter J, Desper R, et al. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization [J]. Am J Pathol, 1999, 155(1):267- 274.
  • 7Shuster MI, Han L, Le Beau MM, et al. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification [J]. Genes Chromosomes Cancer, 2000, 28(2):153- 163.
  • 8Bekri S, Adelaide J, Merscher S, et al. Detailed map of a region commonly amplified at 11q13-q14 in human breast carcinoma [J]. Cytogenet Cell Genet, 1997, 79(1- 2):125- 131.
  • 9Fang Y, Guan XY, Guo Y, et al. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization [J]. Genes Chromosomes Cancer, 2001, 30(3):254- 260.
  • 10Joo M, Kang YK, Kim MR, et al. Cyclin D1 overexpression in hepatocellular carcinoma [J]. Liver, 2001, 21(2):89- 95.

同被引文献26

  • 1邢宝才,袁艳华,胡志国,刘月香,韩燕,刘年,陈慰峰,王歈.NY-ESO-1/LAGE-1基因在肝癌组织中的表达及其诱导的体液免疫应答[J].中华医学杂志,2004,84(23):1980-1982. 被引量:6
  • 2张文敏,肖刚,张萌,谢丹,郭爱林,文剑明.人NY-ESO-1基因的原核表达、纯化和初步应用[J].中国肿瘤临床,2005,32(11):631-634. 被引量:6
  • 3Adams S, O'Neill DW, Nonaka D, et al. Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant [ J ]. J Immunol, 2008, 181 ( 1 ) :776-784.
  • 4Levin D, Constant S, Pasqualini T, et al. Role of dendritic cells in the priming of CD4 ^+ T lymphocytes to peptide antigen in vivo[J]. J Immunol, 1993, 151 (12) : 6742-6750.
  • 5Sehott M, Feldkamp J, Lettmann M, et al. Dendritic cell immunotherapy in a neuro-endocrine pancreas carcinoma [ J]. Clin Endocrinol (Oxf), 2001, 55 (2) : 271-278.
  • 6Odunsi K, Jungbluth AA, Stockert E, et al. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer [J].Cancer Res, 2003, 63 ( 18 ) : 6076-6083.
  • 7Perez D, Herrmann T, Jungbluth AA, et al. Cancer testis antigen expression in gastrointestinal stromal tumors : new markers for early recurrence [J]. Int J Cancer, 2008, 123(7) :1551-1555.
  • 8Jager E, Chen YT, Drijtlaout JW, et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NYESO-1 : definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes [ J]. J Exp Med, 1998, 187(2) : 265-270.
  • 9Luo G, Huang S, Xie X, et al. Expression of cancer-testis genes in human hepatocellular carcinomas [J]. Cancer Immun, 2002, 2(1) :11-20.
  • 10Korangy F, Ormandy LA, Bleck JS, et al. Spontaneous tumorspecific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma [ J ]. Clin Cancer Res, 2004, 10 ( 13 ) : 4332-4341.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部